"Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"

Recruiting Phase 2 Phase 3 Interventional Study
Rheumatoid Arthritis
Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Trial phase
Phase 2/3
Study type
Interventional
Purpose
Treatment
Participants needed
46 (estimated)
Sponsor
University of Guadalajara · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The objective of this clinical trial is to determine whether α-tocopherol (vitamin E) supplementation decreases inflammation and clinical activity in patients with rheumatoid arthritis (RA).The main questions to be answered are: * Is supplementation with vitamin E (α-tocopherol) for one month associated with decreased clinical activity and inflammation in patients with RA? Researchers will compa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Female sex * RA classification (ACR/EULAR 2010) * Early RA 2 years * Treatment with conventional synthetic FARMEs (Metrotexato, Hydroxychloroquine, Leflunomide, Sulfasalazina and their combinations) * DAS28 ≥3.2 * Vitamin E intake deficiency (\<15mg/day) * No comorbidities * A…
Contacts

Christian Johana J Baños Hernández, D.Sc.

+54 10585200 ó 7471493487

johana.banos@academicos.udg.mx

CONTACT

Martin De Leon Cid, B.Nutr.

+54 4931817830

martin.deleon9901@alumnos.udg.mx

CONTACT